心脏纤维化影像学:从AJR纤维化影像学专题系列看最新进展
心肌纤维化是细胞外基质蛋白过度产生和沉积导致病理性心肌重构,分为替代性、反应性和浸润性间质纤维化三型。超声、核医学和CT在评估中起重要作用,但MRI为核心,晚期钆增强(LGE)技术用于诊断、病因鉴别、预后和风险分层,并指导消融管理;T1 mapping和细胞外容积可检测弥漫性纤维化并监测疾病进展和治疗反应。
要点
- LGE MRI是评估心肌纤维化的核心手段,重点观察钆蓄积的模式和分布,用于诊断和鉴别缺血性与非缺血性心肌病。
- LGE MRI还用于预后判断、风险分层以及指导心律失常消融患者的治疗管理。
- T1 mapping和细胞外容积测量可检测和量化LGE MRI可能无法检测的弥漫性纤维化,并监测疾病进展和治疗反应。
核心结论
- 本综述更新了心肌纤维化的影像学评估,涵盖预后和风险分层工具、电生理考量以及疾病监测。
研究设计与样本
- 综述,总结了心肌纤维化的影像学评估进展,包括预后和风险分层工具、电生理考量及疾病监测。
关键影像表现/征象
- 心肌纤维化为细胞外基质蛋白过度产生和沉积导致的病理性心肌重构,分为替代性纤维化(组织坏死所致)、反应性纤维化(心肌应力所致)和浸润性间质纤维化(如淀粉样物质等不可降解物质进行性沉积所致)三型。
- LGE技术聚焦于钆在心肌内蓄积的模式和分布,辅助诊断和明确缺血性与非缺血性心肌病的病因。
诊断标准与关键数值
- LGE MRI以钆蓄积的模式和分布为核心观察终点,用于诊断和明确缺血性与非缺血性心肌病的病因。
- T1 mapping和细胞外容积测量可检测和量化LGE MRI可能无法检测的弥漫性纤维化。
临床应用与阅片要点
- LGE MRI用于预后判断和风险分层。
- LGE MRI用于指导考虑消融治疗心律失常患者的管理。
- T1 mapping和细胞外容积测量用于监测疾病进展和治疗反应。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Myocardial fibrosis (MF) is defined as excessive production and deposition of extra-cellular matrix proteins that result in pathologic myocardial remodeling. Three types of MF have been identified: replacement fibrosis from tissue necrosis, reactive fibrosis from myocardial stress, and infiltrative interstitial fibrosis from progressive deposition of nondegradable material such as amyloid. Although echocardiography, nuclear medicine, and CT play important roles in the assessment of MF, MRI is pivotal in the evaluation of MF, with the late gadolinium enhancement (LGE) technique used as a primary end point. The LGE technique focuses on the pattern and distribution of gadolinium accumulation in the myocardium and assists in the diagnosis and establishment of the cause of both ischemic and nonischemic cardiomyopathy. LGE MRI also aids prognostication and risk stratification. In addition, LGE MRI is used to guide the management of patients considered for ablation for arrhythmias. Parametric mapping techniques, including T1 mapping and extracellular volume measurement, allow detection and quantification of diffuse fibrosis, which may not be detected by LGE MRI. These techniques also allow monitoring of disease progression and therapy response. This review provides an update on the imaging of MF, including prognostication and risk stratification tools, electrophysiologic considerations, and disease monitoring.
引用
- Karur GR, Aneja A, Stojanovska J, et al. Imaging of Cardiac Fibrosis: An Update, From the AJR Special Series on Imaging of Fibrosis. AJR Am J Roentgenol. 2024. PMID: 37753860. doi:10.2214/AJR.23.29870
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。